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The authors investigated the life cycle of Epstein-
Barr virus (EBV) in keratinocytes of oral hairy leu-
koplakia by combining immunohistochemistry, DNA
in situ hybridization, and lectin histochemistry with
electron microscopy. Diffuse-staining components of
the EBV early antigen complex (EA-D), EBV 150-kd
capsid antigen (VCA), EBV membrane antigen
(gp350/220), and double-strandedDNA were labeled
with monoclonal antibodies. An EBV-DNA probe was
used to locate EBV DNA. Wheat-germ agglutinin
(WGA) was employed to distinguish Golgi-asso-
ciated compartments. The authors found EBV pro-
teins andEBVDNA only in keratinocytes with appar-
ent viral assembly. In situ hybridization showedEBV
DNA in free corelike material and in electron-dense
cores of mature nucleocapsids. Monoclonal antibod-
ies to nonspecific double-stranded DNA attached to
the same structures and to marginated chromatin.
Components ofEA-D were dispersed throughout the
nuclei but accumulated near condensed chromatin
and in punched-out' regions of the chromatin. Ep-
stein-Barr virus 150-kd capsid antigen was found
only in the nuclei, where it appeared preferentially
on mature nucleocapsids. As yet unexplained arrays
of intranuclear particles that remained unlabeled
with all EBV-specific probes reacted intensely with
an antiserum against common papillomavirus an-
tigen. Gp350/220 was detectable in various cellular
membrane compartments and was highly concen-
trated on EBV envelopes in peripheral Golgi-associ-
ated secretory vesicles. It was less abundant on the
extracellular EBV, indicating that viral membrane
antigen partly dissociates from the mature virus.
Combined lectin-binding histochemistry and elec-
tron microscopy demonstratedfor the first time that
EBV is processed in the Golgi apparatus, which even-
tually releases the virus by fusion witb the plasma
membrane. These results provide insight into the bi-
ologic events that occur during complete EBV repli-
cation in vivo. (AmJPathol 1991, 139:185-197)
Epstein-Barr virus (EBV) infects more than 90% of the
adult population worldwide1 and remains in a fine bal-
ance with the immune system for the lifetime of the in-
fected host.2 Because the virus replicates at a low rate in
healthy persons, the site of continuous and controlled
EBV production has long remained obscure.
Since the discovery of EBV by Epstein and Barr in
1964,3 assembly of the virus has been observed only in
stimulated or superinfected cultures of latently infected B
cells. Recent data, however, suggest that epithelial cells
may be primary sites of EBV replication.4-8
Human immunodeficiency virus (HIV)-induced de-
pression of the immune system can disturb the equilib-
rium between EBV and its host.9 This disequilibrium
seems to permit the complete replication of EBV in cer-
tain oral epithelial sites, which may lead to the develop-
ment of hairy leukoplakia, a lesion that most commonly
appears on the lateral borders of the tongue of HIV-
infected individuals10 1 (Figure 1).
Electron-microscopic investigations on hairy leuko-
plakia have provided details about ultrastructural pat-
terns associated with EBV production in permissive cells
in vivo."-19 Immunohistochemistry11,12 and in situ
hybridization2 22 have given insight into the distribution
of EBV antigens and DNA in hairy leukoplakia. By them-
selves, however, these methods are not sufficient to show
the assembly and intracellular pathway of EBV as well as
the composition of most of the ultramorphologic alter-
ations described in EBV-producing cells. In this study, we
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Figure 1. Pronounced oral bai-y leukoplakeia sbowing corrugations at margin of tongue.
investigated the distribution and the pathway of EBV
components by combining electron microscopy with im-
munohistochemistry, DNA in situ hybridization, and lectin
histochemistry.
Hairy leukoplakia also exhibits histopathologic fea-
tures that are similar to those found in human papilloma-
virus infection and harbors intranuclear particles that re-
semble papillomaviruses. The positive staining of nuclei
in epithelial cells of the upper prickle cell layers of hairy
leukoplakia with a rabbit serum against common papillo-
mavirus antigen10' 11'16 and with probes for human pap-
illomavirus DNA23'24 has been controversial.12'19'22 We
therefore also sought to determine the ultrastructural
binding sites for the antiserum against papillomavirus.
Materials and Methods
We obtained punch biopsy specimens of clinically sug-
gested hairy leukoplakia from eight HIV-seropositive men
aged 25 to 40 years. As negative controls, we used nor-
mal-appearing tissue from the vicinity of the lesions and
biopsy specimens of oral gingival warts from two addi-
tional HIV-infected patients. All gave informed consent to
provide tissue for the study. The biopsy specimens, taken
after local infiltration with Xylocaine (Astra, Westboro, MA;
1 ml, epinephrine 1 :100,000), were cut into blocks mea-
suring 1 mm x 1 mm x t mm (where t equals thickness
of epithelium) and immediately fixed in 4% paraformal-
dehyde for 2 hours.
Specimens from each case were prepared by two
different procedures. The first procedure involved em-
bedding tissue blocks in methacrylates; several blocks
from each case were embedded in Lowicryl K4M (Che-
mische Werke, Waldkreiburg, FRG) (hydrophilic) and
Lowicryl HM20 (hydrophobic). In the second procedure,
tissue blocks were infiltrated successively with 10%,
20%, 1.2 mol/I (molar), and 2.3 mol/l sucrose in phos-
phate-buffered saline (PBS, pH 7.2) and eventually
shock-frozen in slush nitrogen (-210°C).
Immunoelectron microscopy and DNA in situ hybrid-
ization were performed on ultrathin sections of both meth-
acrylate-embedded and shock-frozen specimens from
six patients. In situ hybridization was also carried out on
Epon-embedded (Ladd Research Industries, Burlington,
VT) sections from two patients.
Immunoelectron microscopy was performed as de-
scribed elsewhere.25 Briefly, nonspecific binding sites
were blocked first with 0.1% gelatin and 0.5% bovine
serum albumin in PBS, and subsequently with goat non-
immune serum. Next the sections were incubated for 1
hour with affinity-purified monoclonal antibodies (MAb)
specific against different epitopes of galactosidase-fused
EBV proteins that we produced in Escherichia coli. The
MAbs were directed against the following antigens: EBV-
-6-o% C:;
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membrane antigen gp350/220 of reading frame
BLLF1 26 EBV-capsid antigen p150 of reading frame
BcLF1 ,27 and EBV-early antigen D p138 of reading frame
BALF2.28 All MAbs were characterized inasmuch as they
reacted with cloned recombinant products of the respec-
tive proteins.2628
We also applied the following commercially available
MAbs against EBV antigens: Anti-EBV VCA IgGl (MAb
9247/003; DuPont, Billerica, MA) and IgG2a (MAb 9246/
003; DuPont), anti-EBV VCA IgG1 k (MAb 817, Chemicon,
Temecula, CA), anti-EBV EA-D IgGl (MAb 9240/002; Du-
Pont), and anti-EBV MA IgG1 k (MAb 813, Chemicon, El
Segundo, CA). In addition, we applied commercially
available MAb against double-stranded DNA (IgG2a,k;
MAb 030/1613, Chemicon), herpes simplex virus type
IgGl (MAb 9251/002; DuPont), and cytomegalovirus
(CMV) late nuclear protein IgG3 (MAb 9220/4304; Du-
Pont). Finally we concentrated a rabbit antiserum against
bovine ('common') papillomavirus antigen (Dako, Santa
Barbara, CA) by the factor 10 in Centricon centrifugal
microconcentrators (Amicon, Danvers, MA) at 4000 rpm
and 40C in a Sorvall RC2-B centrifuge for 2 hours imme-
diately before the immunoincubation.
The immunoincubated sections were subsequently
labeled with affinity-purified goat anti-mouse IgG, goat
anti-rabbit IgG, or protein G, conjugated with colloidal
gold particles, 1 nm or 5 nm in size (Janssen, Beerse,
Belgium). Protein G is a cell wall component of group G
streptococci and exhibits IgG-binding properties similar
to those of protein A, which is a cell wall component of S.
aureus.
For indirect lectin-binding histochemistry, we conju-
gated ovomucoid (Sigma, Type 111-0) with 10-nm colloi-
dal gold particles (Janssen, Beerse, Belgium) as de-
scribed previously.29'30 We incubated Lowicryl-
K4M-embedded sections with a solution of wheat-germ
agglutinin (WGA, Sigma) in PBS (100 mg/ml) for 1 hour,
and then labeled the lectin-binding sites with the ovomu-
coid-gold conjugate, applied for 30 minutes.
In situ DNA hybridization was performed with biotiny-
Figure 2. EBV-producing keratinocivtes in
upper third of the epithelium of oral hairp
leukoplakia. Note the i)pical ultrastructural
appearances: (1) intranuclear arrays, (2) nu-
cleocapsids, (3) extracellular EBV, and (4)
marginated chromatin. Bar represents I ,u
(X 10,000).
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Figure 3. Condensed and marginated chromatin in nucleus ofEBV-producing keratinocyte after incubation with MAb againstp138 of the
early antigen D complex (EA-D). EA-D has accumulated near marginated chromatin and can be detected in punched-out' regions of the
chromatin (long arrows). Inset: Corresponding area after incubation uith MAb against virus-capsid antigen (150 kd). The punched-out
regions remain without label, uhereas mature nucleocapsids are distinctly marked (short arrows). l ltrathin sections of shock-frozen
specimens. Bars represent 200 nm (x110,000; inset: x60,000).
lated probes on ultrathin sections of shock-frozen, Low-
icryl-embedded, and Epon-embedded specimens. The
procedure and the biotinylated probes are described
elsewhere.2'21 We used the recombinant plasmid probe
pBgl 2-U,31 which is specific for the large internal repeat
sequence of the EBV genome. Tissue-bound probes
were labeled with streptavidin conjugated with colloidal
gold particles, 5 nm in size (Janssen, Beerse, Belgium).
The sections of shock-frozen specimens were stained
with 2% uranyl acetate. The plastic-embedded sections
were stained with saturated uranyl acetate and Reynold's
lead citrate. All specimens were examined at 80 kV with
a Jeol JEM-1200 EX electron microscope.
Results
Of the immunoelectron-microscopic methods applied,
the preparation of ultrathin sections of shock-frozen spec-
imens provided the most intense and most specific im-
munolabeling. Each antigen showed the same distribu-
tion in all cases. Epstein-Barr virus proteins and DNA
were detected only in keratinocytes with apparent viral
assembly in the upper prickle-cell layers of the epithelium
(Figure 2); they were not found in the control tissue.
Monoclonal antibodies specific to different epitopes of
the same protein showed principally the same label pat-
tern, although with varying intensity. The antibodies
against herpes simplex virus type and CMV did not
react with either hairy leukoplakia or the control tissue.
The components of the early antigen D complex (EA-
D) that were detected with our antibodies were diffusely
distributed throughout the nuclei (Figure 3). Early antigen
D was found near condensed chromatin and was usually
attached to relatively undefined, homogeneous compo-
nents of various electron densities. Unlike the other anti-
gens examined in this study, EA-D was detected in
'punched-out' regions of condensed and marginated
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Figure 4. Portion of nucleus of EBV-producing keratinocy'te after incubation with MAb against virus capsid antigen (VCA). Note the
association ofantigen with mature EBV nzucleocapsids (arrous), distinguisbable by the higher electron densitq, oftheir cores. Ultrathin section
ofshock-frozen specimen. Bar represents 200 nm (x 56,000).
chromatin, common features in EBV-producing kerati-
nocytes of hairy leukoplakia. Early antigen D was not no-
ticed in intranuclear arrays of electron-dense particles,
usually about 35 nm in diameter.
Virus capsid antigen (VCA) was found exclusively in
the nuclei of EBV-producing keratinocytes. It was mostly
associated with morphologically well-defined EBV nucle-
ocapsids at advanced stages of maturation (Figure 4).
Once the EBV capsids were enveloped at the nuclear
membrane, their VCA was no longer detectable (data not
shown). The intranuclear arrays of electron-dense parti-
cles were also negative for VCA.
The MAbs against double-stranded DNA reacted with
marginated chromatin, cores of viral nucleocapsids, and
free, electron-dense intranuclear condensations (Figure
5). Unlike VCA, intraviral DNA was also observed on the
shells of less condensed cores of nucleocapsids.
The unembedded and fragile ultrathin sections of
shock-frozen specimens lost most of their structure dur-
ing the procedure of DNA in situ hybridization with pBgl
2-U. Therefore we could evaluate only the sections em-
bedded in Lowicryl and Epon. They did not seem to be
altered by the hybridization procedure, but showed only
weak reactivity with our DNA probes. Epstein-Barr virus
DNA was found in the nuclei on condensations resem-
bling free corelike material and occasionally on electron-
dense cores of nucleocapsids (Figure 6). Antibody
against nonspecific double-stranded DNA also labeled
these structures in addition to marginated chromatin (Fig-
ure 5).
The antiserum against papillomavirus antigen strongly
reacted with the arrays of intranuclear particles (Figure
7B) that remained unlabeled after incubation with the
other probes applied in this investigation. The antiserum
also reacted with intranuclear structures of keratinocytes
in oral warts that we used as control tissue (data not
shown).
Membrane antigen (gp350/220) was detected on var-
ious membrane compartments of EBV-producing cells.
Occasionally we found high amounts of gp350/220 on
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Figure 5. Nucleus of EBV-producing keratinocyte after incubation uitb MAb against double-stranded DNA. 7Te chromatin is intensely
labeled. Note the shell-like gold label on the core surface ofEBV nucleocapsids (arrouws). Ultrathin section of shock-frozen specimen. Bar
represents 100 nm (x 110,000).
the outside of the nuclear membrane, but it seemed to be
more abundant on enveloped EBV capsids that ap-
peared in groups in cytoplasmic vacuoles near the cel-
lular membrane (Figure 8). Most of the extracellular EBV
had fewer gp350/220-containing membrane projections
on their envelopes than did the cytoplasmic EBV. Gp350/
220 could sometimes be detected on the membranes of
the vacuoles themselves and on the cell membrane. On
rare occasions, small amounts of the antigen were found
in the nuclei near the nuclear membrane.
The peripheral cytoplasmic vesicles that contained
groups of complete EBV particles were heavily and dis-
tinctively labeled with WGA (Figure 9A), which distin-
guishes them as Golgi-associated secretory vesicles.
They released the processed virus by fusing with the
plasma membrane (Figure 9B). Envelope and tegument
of peripheral intravesicular and extracellular EBV were
most intensely labeled with WGA.
Discussion
Oral keratinocytes infected with EBV give rise to the only
known lesion in which EBV undergoes complete in vivo
replication. Because of its clinical appearance, the lesion,
which usually appears at the lateral borders of the tongue
of severely immunosuppressed persons, has been
named oral hairy leukoplakia. Only a few light-micro-
scopic investigations have described the distribution of
viral components in hairy leukoplakia.'1,122022 One ad-
ditional light-microscopic study described the intracel-
lular localization of gp350/220 in the Golgi apparatus.32
Those data, however, do not provide direct insight into
the sequence of viral assembly and the intracellular path-
way of EBV components. Several investigators described
the ultrastructural alterations specific for EBV-producing
keratinocytes in hairy leukoplakia.'1 1-19 Yet the composi-
tion of most ultrastructural features has remained unclear.
In this study, combining immunohistochemistry, lectin-
binding histochemistry, and DNA in situ hybridization with
electron microscopy has allowed us to gain direct insight
into the molecular composition of some characteristic ul-
trastructural features of hairy leukoplakia and to correlate
them to the distribution and the pathway of EBV constit-
uents.
Viral cores and capsids are assembled in the nuclei of
EBV-producing keratinocytes that are found in the upper
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Figure &. Nucleus ofEBV-producing keratinocote afterDNA in situ h¶bridization. EBVDNA is detected onfree corelike material (long arrow)
and on electron-dense cores of nucleocapsids (short arrou). Ultrathin sections ofEpon-embedded specimens. For both illustrations the bar
represents 100 nm (x 140,000).
prickle-cell layers of the epithelium. It might be thought
that EBV DNA would be replicated in deeper layers and
assembly of the translational products would take place
in the upper third of the epithelium. We found three EBV
antigens early antigen, capsid antigen, and membrane
antigen-as well as EBV DNA only in EBV-producing
cells of the upper third of the epithelium, providing evi-
dence that both replication and assembly are linked to
epithelial differentiation.
The plastic-embedded sections prepared for DNA in
situ hybridization allowed only very weak labeling, as
compared with the intensity achieved by light-microscop-
ic techniques.'22 The weakness was probably due to
the strong cross-linking of already sparse EBV-DNA de-
terminants available in ultrathin sections. The poor label-
ing obviously does not exclude the occurrence of EBV in
lower epithelial layers, although the complete lack of de-
tectable EBV DNA in our system suggests a much lower
amount in lower cell layers. This indication of an explosive
initiation of a differentiation-linked EBV replication corre-
sponds with previous light-microscopic observa-
tions.222 In addition, the labeling was highly specific
and appeared mainly on condensations of free core ma-
terial and electron-dense cores of nucleocapsids.
The MAb against double-stranded DNA applied on
ultrathin frozen sections showed the same distribution, in
addition to a strong labeling of marginated chromatin.
Although labeling of double-stranded DNA would be
weak evidence for EBV DNA at the light-microscopic
level, the combined observation of the ultrastructurally
defined nucleocapsids and double-stranded DNA
strongly indicates integrated EBV DNA.
Even though components of the early antigen D com-
plex usually can be found in both the nuclei and the cy-
toplasm of EBV-producing cells, our MAb reacted only
with intranuclear components, as described previously in
Raji cells.33 We found the early antigen p138 rather dif-
fusely distributed throughout the nuclei and, unlike the
other viral proteins, accumulated along marginated chro-
matin and in its punched-out regions. Early antigen in-
duces the replication of the EBV genome and the syn-
thesis of structural viral proteins.' Hence the accumula-
tion of p138 at and in cellular chromatin could indicate
integrated EBV DNA. Epstein-Barr virus DNA has previ-
ously been demonstrated to be integrated into the DNA
of Namalwa cells35 and may be associated with meta-
phase chromosomes.36 It has not yet been shown
whether p138 binds specifically to EBV sequences, how-
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Figure 7. Nucleus ofEBV-producing keratinociyte (A) after incubation uith MAb against double-strandedDNA and (B) after incubation with
antiserum against common papillomavirus antigen. Note the specific labeling of the arrayled particles u'ith the antiserum against papillo-
mavirus antigen, uhereas the clumped chromatin remainsfree of label. Lltrathin sections of shock-frozen specimens. For A and B the bar
represents 100 nm (xIO0,O000).
ever. Hence its peculiar distribution may be attributable to
nonspecific binding to components of the host cell chro-
matin.
Virus capsid antigen was mainly detectable on core-
containing nucleocapsids at advanced stages of matu-
ration. Only these mature nucleocapsids are translocated
into the cytoplasm by envelopment at the nuclear mem-
brane, as we described recently.37 Envelopment of
herpes simplex virus seems to depend on the completion
of DNA packaging and the length of the assembled viral
DNA.38 For EBV, we additionally found here that assem-
bly of the 150-kd capsid antigen seemed to coincide with
the final stages of DNA packaging. Hence DNA packag-
ing seems to be crucial for the assembly of VCA, which in
turn seems to be important for the envelopment of the
completed viral capsids at the nuclear membrane. This
notion is supported by the previous observation of empty,
thus DNA-free, EBV capsids that accumulated in the nu-
clei of superficial keratinocytes.37 Furthermore we found
here that enveloped capsids were not labeled with the
MAb against VCA, indicating that antigenic sites of the
150-kd protein were shielded by juxtaposing or perhaps
even interacting tegument proteins or the envelope.
Unlike VCA and EA-D, membrane antigen (gp350/
220) was found mostly on extranuclear enveloped EBV,
which frequently collected in groups within cytoplasmic
vesicles. We were unable to detect gp350/220 on thick-
ened and reduplicated nuclear membranes, which occur
in herpesvirus-producing cells and are thought to harbor
virus-specific proteins.39-40 The fact that the MAb against
gp350/220 most strongly labeled EBV envelopes in pe-
ripheral cytoplasmic vesicles suggests that the MAb
used are directed toward glycosylated epitopes of
gp350/220. This is not unlikely, because about 50% of the
gp350 mass consists of carbohydrates.41 It is also con-
sistent with the observations that the glycosylated forms
of gp350/220 are stronger immunogens than unglycosy-
lated gp350/220 core proteins,42 and that our own MAbs
failed to react with gp350/220 produced in insect cells
(data not shown) that glycosylate proteins differently.
Hitherto it has not been clear how EBV is processed
and released by its host cells.3-439-40 Our data show, un-
ambiguously and for the first time, that EBV follows the
same physiologic pathway as cellular proteins during
their final processing and egress. In another study, a 165-
kd protein was indirectly shown to be processed and
glycosylated to gp350/220 in the Golgi apparatus of
P3HR-1 cells.32 It remained unclear, however, whether
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Figure 8. Periphery ofEBV-producing keratinocyte after incubation u'ith 4,MAb against membrane antigen (gp350/220). A: Enveloped EBV
in the peripheral cytoplasmic vacuole (long arrou) is more intensely labeled than extracellular EBV (short arrows). B: Extracellular EBV
is labeled exclusiveely at electron-dense structures projecting out of the viral envelope (long arrow), whereas gp3501220 cannot be detected
on EBV without projections (short arrou). C: K-xtracellular EBV seems to be linked to the plasnia membrane via a gp3501220-positive
projection of its envelope (arrou'). lltrathin sections ofshock-frozen specimens. For A, B, and C, the bar represents 200 nm (x90,000).
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Figure 9. Periphery ofEBV-producing keratinoci'te after incubation with uheat-germ agglutinin (WGA) labeled with ovomucoid-conjugated
gold (10 nm in diameter). WGA binds to N-acetvlglucosamine and stains the Golgi apparatus relativel/v specificallv, but not the endoplasmic
reticulum27'36 EBV appears in groups u'ithin peripheral vesicles of the Golgi apparatus (A), uwhich eventually open to the cell surface by
membranefusion to release the processed virus (B). FBV envelope (long arrouws) and tegument (short arrou s) are most intensely labeled.
Ultrathin sections ofLowicrml K41-embedded tissue. For A and B, the bar represents 100 nm (X 5-3,000)
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Figure 10. EBV-producing keratinocyte in
oral hairy leukoplakia. (1) Early antigen was
found in punched-out areas of marginated
chromatin, which also was intensely labeled
for double-stranded DNA. (2) EBVDNA (large
internal repeat) was detected on condensa-
tions resembling free core material. (3) Virus
capsid antigen wasfound on mature nucleo-
capsids. Their cores were also labeled with
MAbs against dsDNA. (4) After envelopment at
the nuclear membrane, virus capsid antigen
was obscured by the adjacent membrane. (5)
Intranuclear arrays of electron-dense parti-
cles reacted exclusivelv uith an antiserum
against papillomavirus antigen. (6) Envel-
oped EBV in Golgi-associated vesicles (GAV)
reacted with MAb against gp350/220 and
wheat-germ agglutinin, u'hicb specifically la-
bels the Golgi apparatus and its products by
binding to N-acetylglucosamine. (7) EBV uwas
released by fusion of GAV and the plasma
membrane. (8) WGA stained extracellular
EBV most intensely. ER, endoplasmic reticu-
lum; N, nucleus; GA, Golgi apparatus.
the final processing of gp350/220 precursors took place
before or after their integration into the EBV envelopes. In
Golgi-associated secretory vesicles of the keratinocytes
we examined, gp350/220 was preferentially attached to
EBV and only occasionally found on the membranes of
the vesicles themselves, whereas virus-free vacuoles did
not harbor any detached gp350/220. This indicates that
gp350/220 is processed in the Golgi complex of EBV-
producing cells after assembly into the viral surface. Our
finding that tegument and envelope of EBV particles in
peripheral Golgi-associated vesicles were heavily la-
beled with WGA further supports the idea that EBV gets
its final modification in the Golgi apparatus. We also dem-
onstrated that completed EBV is released by fusion of the
Golgi-associated secretory vesicles with the plasma
membrane. This suggests that egress of EBV depends
on physiologic secretory mechanisms of the cell rather
than on gp350/220 epitopes that regulate trafficking and
release of EBV.4243
Less gp350/220 was detected on extracellular EBV
that also lacked surface projections; together these ob-
servations indicate that membrane antigen is shed from
the virus rather than blocked by diffusing host antibodies.
Antibodies directed toward gp350/220 neutralize infec-
tivity of EBV44 and mediate antibody-dependent cytotox-
icity of K cells.45 Shed viral surface protein might there-
fore bind and deplete protective antibodies against
gp350/220, thus providing a means for EBV to evade the
humoral response of the host.
The selective attachment of the MAb to matured viral
structures, as demonstrated for VCA and gp350/220, in-
dicates that the viral antigens are continuously processed
after their putative production at the ribosomes of the en-
doplasmic reticulum. Even though these 'mature' EBV
proteins are presumably the most immunogenic, some
MAb may also be specific to less processed determi-
nants and attach to different ultrastructural features.
Our results provide, for the first time, direct insight into
the biology of EBV in its naturally permissive cell, the ke-
ratinocyte. As summarized in Figure 10, they disclose
parts of the intracellular pathway of EBV, its components,
and their relation to typical ultrastructural features of hairy
leukoplakia. The composition of some common fine-
structural appearances, however, remains unclear.
We1037 and others19 previously described arrayed het-
eromorph and hollow-cored particles in the nuclei of EBV-
producing keratinocytes. Similar structures have also
been described in cells infected with other herpes-
viruseS394649 and have been interpreted as partly ag-
gregated capsids.39 The evidence that these structures
are related to herpesviruses is circumstantial, however,
and relies heavily on the observation that structures mor-
phologically indistinguishable from small ringlike compo-
nents have been observed in immature nucleocapsids of
herpes simplex virus-1,5i equine herpesvirus-1,51
Marek's disease virus, and herpes virus of turkeys.52 We
previously described tubular structures in hairy leuko-
plakia that were associated with arrays of partially hollow-
cored particles.37 Their proximity and compatible caliber
suggest that these tubules may consist of linear aggre-
gations of structural components of the granules. Intra-
nuclear tubular structures also were found in association
with intranuclear arrays of other herpesvirus-infected
cells48,49'53'54 and were considered to be a feature of
herpesviruses with oncogenic potential,' which is con-
sistent with the well-known oncogenicity of EBV. In this
study, we observed similar tubular fragments that were
interwoven with the papillomavirus-antigen-positive ar-
rays. None of the other probes we used reacted with
these ultrastructural features.
* *
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The heterogenous probes used in combination with
immunoelectron microscopy in this study have given us a
better understanding of the biologic events that occur
during complete EBV replication in the keratinocyte. Be-
cause of the lack of ultrastructural alterations and the low
concentration of viral antigens in latently infected cells,
immunoelectron-microscopic analysis may not show
much beyond that already obtained by light-micro-
scopic investigation. The investigation of the ultrastruc-
tural distribution of additional late viral proteins and cel-
lular antigens, however, may further improve our under-
standing of EBV-cell interactions in vivo.
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